Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Mar 01, 2024 (filed on Mar 06, 2024)Insider Name:Silvestro Stephen LOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-1,927Price:--
-
Mar 01, 2024 (filed on Mar 06, 2024)Insider Name:Silvestro Stephen LOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-668Price:$15.95
-
Mar 01, 2024 (filed on Mar 06, 2024)Insider Name:Silvestro Stephen LOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:1,927Price:--
-
Mar 01, 2024 (filed on Mar 06, 2024)Insider Name:Odence-Ford MarionOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-771Price:--
-
Mar 01, 2024 (filed on Mar 06, 2024)Insider Name:Odence-Ford MarionOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-268Price:$15.95
-
Mar 01, 2024 (filed on Mar 06, 2024)Insider Name:Odence-Ford MarionOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:771Price:--
-
Feb 11, 2024 (filed on Feb 13, 2024)Insider Name:Odence-Ford MarionOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-4,000Price:--
-
Feb 11, 2024 (filed on Feb 13, 2024)Insider Name:Odence-Ford MarionOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-1,386Price:$15.39
-
Feb 11, 2024 (filed on Feb 13, 2024)Insider Name:Odence-Ford MarionOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:4,000Price:--
-
Feb 02, 2024 (filed on Feb 06, 2024)Insider Name:Klema CathyOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:5,109Price:--
Filings by filing date
-
Mar 01, 2024 (filed on Mar 06, 2024)Insider Name:Silvestro Stephen LOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-1,927Price:--
-
Mar 01, 2024 (filed on Mar 06, 2024)Insider Name:Silvestro Stephen LOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-668Price:$15.95
-
Mar 01, 2024 (filed on Mar 06, 2024)Insider Name:Silvestro Stephen LOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:1,927Price:--
-
Mar 01, 2024 (filed on Mar 06, 2024)Insider Name:Odence-Ford MarionOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-771Price:--
-
Mar 01, 2024 (filed on Mar 06, 2024)Insider Name:Odence-Ford MarionOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-268Price:$15.95
-
Mar 01, 2024 (filed on Mar 06, 2024)Insider Name:Odence-Ford MarionOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:771Price:--
-
Dec 19, 2023 (filed on Feb 21, 2024)Insider Name:Besch DougOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:5,892Price:--
-
Dec 19, 2023 (filed on Feb 21, 2024)Insider Name:Besch DougOwnership Type:Direct OwnershipSecurities:Stock OptionNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:5,892Price:--
-
Dec 19, 0023 (filed on Feb 21, 2024)Insider Name:Stelmakh EdwardOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:15,711Price:--
-
Dec 19, 0023 (filed on Feb 21, 2024)Insider Name:Stelmakh EdwardOwnership Type:Direct OwnershipSecurities:Stock OptionNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:15,711Price:--
News
Biz Brief
Sector: Technology | Industry: Internet Services |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 260 CHARLES STREET, SUITE 302 WALTHAM MA 02453 |
Tel: | N/A |
Website: | https://www.optimizerx.com |
IR: | See website |
Key People | ||
Stephen L. Silvestro President, Chief Commercial Officer | William J. Febbo Chief Executive Officer, Director | Edward Stelmakh Chief Financial Officer, Chief Operating Officer |
Karina Castagna Senior Vice President - Access and Adherence | Todd Inman Chief Technology Officer | Marion K. Odence-Ford Chief Compliance Officer, General Counsel | Doug Besch Chief Product Officer |
Business Overview |
OptimizeRx Corporation is a digital health technology company, which enables engagement between life sciences organizations, healthcare providers and patients. The Company's principal solutions include evidence-based physician engagement, point of care banner messaging, social network banner messaging, institutional account-based banner messaging, financial messaging, patient engagement and therapy initiation workflow. Its evidence-based physician engagement solution uses predictive analytics via machine learning methods applied to real-world data (RWD) to assist healthcare providers (HCPs). Its point of care banner messaging solution utilizes to deliver a variety of awareness and messaging within the clinical workflow, which can be tailored to meet the needs of each brand. Its Institutional Account-based Banner Messaging solution provides its clients access to delivering banner messaging online and on the intranets of targeted health system accounts. |
Financial Overview |
For the nine months ended 30 September 2023, OPTIMIZERx Corp revenues increased 1% to $43.2M. Net loss increased 21% to $13.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Basic Earnings per Share excluding Extraordinary Items decreased from -$0.62 to -$0.79. |
Employees: | 109 as of Dec 31, 2022 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $157.01M as of Sep 30, 2023 |
Annual revenue (TTM): | $62.81M as of Sep 30, 2023 |
EBITDA (TTM): | -$14.51M as of Sep 30, 2023 |
Net annual income (TTM): | -$13.75M as of Sep 30, 2023 |
Free cash flow (TTM): | -$0.00M as of Sep 30, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 18,152,478 as of Nov 10, 2023 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |